Home Cart 0 Sign in  

[ CAS No. 1093192-07-4 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1093192-07-4
Chemical Structure| 1093192-07-4
Structure of 1093192-07-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 1093192-07-4 ]

Related Doc. of [ 1093192-07-4 ]

Alternatived Products of [ 1093192-07-4 ]

Product Details of [ 1093192-07-4 ]

CAS No. :1093192-07-4 MDL No. :MFCD16293742
Formula : C11H22N2O4 Boiling Point : -
Linear Structure Formula :- InChI Key :UTWVEOUYCGZORL-SSDOTTSWSA-N
M.W :246.30 Pubchem ID :45382265
Synonyms :

Calculated chemistry of [ 1093192-07-4 ]

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.82
Num. rotatable bonds : 7
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 63.54
TPSA : 90.65 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.4 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.68
Log Po/w (XLOGP3) : 0.56
Log Po/w (WLOGP) : 0.79
Log Po/w (MLOGP) : 0.61
Log Po/w (SILICOS-IT) : 0.11
Consensus Log Po/w : 0.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.26
Solubility : 13.6 mg/ml ; 0.0552 mol/l
Class : Very soluble
Log S (Ali) : -2.04
Solubility : 2.27 mg/ml ; 0.00921 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.43
Solubility : 9.21 mg/ml ; 0.0374 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.96

Safety of [ 1093192-07-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1093192-07-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1093192-07-4 ]
  • Downstream synthetic route of [ 1093192-07-4 ]

[ 1093192-07-4 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 1093192-06-3 ]
  • [ 1093192-07-4 ]
YieldReaction ConditionsOperation in experiment
95% With hydrogen In tetrahydrofuran for 2 h; Inert atmosphere Methyl (2S)-2-amino-3-[(tert-butoxy)carbonyl]amino}-3-methylbutanoate (136): 135 (0.50 g, 1 .4 mmol) is dissolved in anhydrous THF (10 mL) in 50 mL flask and placed under argon. Palladium hydroxide catalyst (0.18 g, 20 wtpercent) is rapidly weight and added to the flask. The flask is then filled with hydrogen and refilled. (-101 kpa). After 2 h, LC/MS showed the reaction is completed. The mixture is filtered through a celite pad, and the filtrate is condensed to dryness. The residue is purified by CombiFlash (eluting with 0-5percent MeOH in DCM) to afford 34 as white solid (330 mg, 95percent yield). 1 H NMR (300 MHz, CDCI3) 51 .30 (s, 3H), 1 .37 (s, 3H), 1 .39 (s, 9H), 3.26 (br s, 2H), 3.71 (s, 3H), 3.87 (s, 1 H), 4.95 (s, 1 H); 13C NMR (75 MHz, CDCI3) δ 24.15, 24.23, 28.55, 52.28, 54.77, 60.55, 79.77, 155.26, 173.41 .
59.3% With hydrogen In tetrahydrofuran at 20℃; for 9 h; Compound III-07 (2.4 g, 6.848 mmol) was dissolved in THF (50 mL), then Pb(OH)2 20percent, 1.3 g) was added. The solution was stirred at room temperature under hydrogen (intensity of pressure: 3.0KG) for 9 h, then filtered and the filtrate was concentrated in vacuo. The residue was purified by chromatography on silica gel with DCM/MeOH (100/1~50/1) to give III-08 (1.0 g, 59.3percent) as a colorless oil. 1H NMR (400 MHz, Chloroform-d) δ 5.03-4.90 (s, 1H), 3.97-3.80 (s, 1H), 3.79-3.70 (s, 3H), 1.52-1.42 (s, 9H), 1.42-1.35 (s, 3H), 1.35-1.28 (s, 3H). MS(EI) m/z: (M+, 246).
Reference: [1] Patent: WO2012/31298, 2012, A2, . Location in patent: Page/Page column 121-122
[2] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 2, p. 94 - 102
[3] Patent: WO2008/154642, 2008, A2, . Location in patent: Page/Page column 245-246
  • 2
  • [ 1093192-03-0 ]
  • [ 1093192-07-4 ]
Reference: [1] Patent: WO2012/31298, 2012, A2,
[2] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 2, p. 94 - 102
[3] Patent: WO2008/154642, 2008, A2,
  • 3
  • [ 1093192-04-1 ]
  • [ 1093192-07-4 ]
Reference: [1] Patent: WO2012/31298, 2012, A2,
[2] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 2, p. 94 - 102
[3] Patent: WO2008/154642, 2008, A2,
  • 4
  • [ 1093192-05-2 ]
  • [ 1093192-07-4 ]
Reference: [1] Patent: WO2012/31298, 2012, A2,
[2] Bioorganic and Medicinal Chemistry Letters, 2018, vol. 28, # 2, p. 94 - 102
[3] Patent: WO2008/154642, 2008, A2,
  • 5
  • [ 1093192-00-7 ]
  • [ 1093192-07-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5002 - 5014
  • 6
  • [ 1093191-99-1 ]
  • [ 1093192-07-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5002 - 5014
  • 7
  • [ 170454-20-3 ]
  • [ 1093192-07-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5002 - 5014
  • 8
  • [ 1219366-49-0 ]
  • [ 1093192-07-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5002 - 5014
  • 9
  • [ 1093192-01-8 ]
  • [ 1093192-07-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5002 - 5014
  • 10
  • [ 1219366-76-3 ]
  • [ 1093192-07-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 5002 - 5014
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1093192-07-4 ]

Amino Acid Derivatives

Chemical Structure| 58561-04-9

[ 58561-04-9 ]

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate

Similarity: 0.87

Chemical Structure| 55747-84-7

[ 55747-84-7 ]

Boc-Asp(Ome)-Ome

Similarity: 0.87

Chemical Structure| 98045-03-5

[ 98045-03-5 ]

Boc-Asp-OMe

Similarity: 0.87

Chemical Structure| 137130-65-5

[ 137130-65-5 ]

Boc-D-Asp-OMe

Similarity: 0.87

Chemical Structure| 363191-25-7

[ 363191-25-7 ]

H-D-Dap(Boc)-OMe

Similarity: 0.87